Key clinical issues in renal cancer: a challenge for proteomics
Related Experiment Video
Updated: Jan 22, 2026

Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression
Published on: January 31, 2025
Rosamonde E Banks1, Rachel A Craven, Patricia Harnden
1Cancer Research UK Clinical Centre, St James's University Hospital, Leeds LS9 7TF, UK. r.banks@leeds.ac.uk
Abstract:
Renal cancer has many clinical challenges which proteomics is ideally placed to address. The issues cover all aspects of the disease including diagnosis, prognosis, treatment selection and monitoring to detect metastatic disease. In all cases novel biomarkers would considerably help in clinical management and with the relative resistance to conventional chemotherapy and radiotherapy, a better understanding of the underlying pathogenesis may contribute to the much needed development of novel therapeutic targets and the better use of promising new anti-angiogenic treatments. This review briefly highlights some of the clinical issues and describes proteomics-based approaches generally, before focussing on reviewing the proteomic studies to date in this area.
Insights
Proteomics offers solutions for renal cancer challenges, aiding diagnosis, prognosis, and treatment. This review explores proteomics studies to find new biomarkers and therapeutic targets for improved patient outcomes.
Area of Science:
- Oncology
- Biochemistry
- Proteomics
Background:
- Renal cancer presents significant clinical challenges across diagnosis, prognosis, treatment selection, and monitoring.
- Current treatments like chemotherapy and radiotherapy show limited efficacy, highlighting the need for novel therapeutic strategies.
- Identifying new biomarkers is crucial for effective clinical management of renal cancer.
Purpose of the Study:
- To review the clinical challenges in renal cancer management.
- To describe general proteomics-based approaches applicable to renal cancer.
- To summarize existing proteomics studies relevant to renal cancer.
Main Methods:
- Literature review of clinical challenges in renal cancer.
- Overview of proteomics methodologies.
- Focused review of published proteomics studies in renal cancer.
Main Results:
- Proteomics can address key clinical issues in renal cancer, including diagnosis and prognosis.
- Novel biomarkers identified through proteomics can significantly improve clinical management.
- Understanding renal cancer pathogenesis via proteomics may lead to new therapeutic targets and better use of anti-angiogenic treatments.
Conclusions:
- Proteomics holds significant promise for advancing renal cancer diagnosis, prognosis, and treatment.
- Further proteomics research is essential for developing targeted therapies and improving patient outcomes.
- Proteomics-based biomarker discovery is critical for personalized medicine in renal cancer.
Related Concept Videos
Key Techniques in Microbiology
Ethical Issues
Ethical Concerns in Healthcare:
Key Elements for Plant Nutrition
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

